Lawsuits Johnson & Johnson subsidiary company Ethicon, Inc. has recently halted sales of their power Morcellators, as federal health regulators have issued warnings regarding the usage of the Power Morcellators. The Food & Drug Administration (FDA) report indicates the device can spread undetected cancer cells when undergoing surgery for hysterectomy or myomectomy for fibroids and have uterine sarcoma (cancer of the muscle & supporting tissues around the uterus).
Power Morcellator Risk
Power Morcellator are small devices that can be used during a hysterectomy or myomectomy to cut tissue through a small incision. Current reports indicate that 1 in 350 women having surgery to remove fibroid also has an undetected uterine sarcoma, cancer of the muscle and uterus tissue. The morcellator has spinning blades and can spread cancerous cells to other organs in the body during the surgery. Because of these reports, the FDA has issued recommendations to physicians to discontinue all use of power Morcellators devices. Some hospitals have gone so far to ban the usage of power Morcellator devices.
FDA Reports & Evaluations
Johnson & Johnson has stopped sales and distribution as a result from the alerts issued by the FDA. It is important to note that Johnson & Johnson has failed to issue a recall of the devices and the Morcellator devices continue to be used for these surgeries by physicians.
For all matters relating to your health, please consult your doctor and not an attorney. Please consult your doctor regarding all medical procedures, medicine dosages and usage. Patients should visit with their doctors or physicians regarding the risk of Power Morecellator usage.